{"id":"https://openalex.org/W3040478654","doi":"https://doi.org/10.2174/1573399816666200705210006","title":"Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus","display_name":"Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus","alternate_titles":[],"publication_year":2020,"publication_date":"2020-07-06","ids":{"openalex":"https://openalex.org/W3040478654","doi":"https://doi.org/10.2174/1573399816666200705210006","mag":"3040478654","pmid":"https://pubmed.ncbi.nlm.nih.gov/32628589"},"language":"en","primary_location":{"id":"doi:10.2174/1573399816666200705210006","doi":"https://doi.org/10.2174/1573399816666200705210006","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1573399816666200705210006","pdf_url":null,"source":{"id":"https://openalex.org/S204739293","display_name":"Current Diabetes Reviews","issn_l":"1573-3998","issn":["1573-3998","1875-6417"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Diabetes Reviews","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3040478654"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001035577","display_name":"Satoshi Ida","orcid":"https://orcid.org/0000-0003-4353-1226","observed_orcids":["https://orcid.org/0000-0003-4353-1226"]},"institutions":[{"id":"https://openalex.org/I4210151610","display_name":"Ise Red Cross Hospital","ror":"https://ror.org/047s1ww61","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210151610"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Satoshi Ida","raw_affiliation_strings":["Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan"],"raw_orcid":"https://orcid.org/0000-0003-4353-1226","affiliations":[{"raw_affiliation_string":"Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan","institution_ids":["https://openalex.org/I4210151610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012727634","display_name":"Ryutaro Kaneko","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151610","display_name":"Ise Red Cross Hospital","ror":"https://ror.org/047s1ww61","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210151610"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ryutaro Kaneko","raw_affiliation_strings":["Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan","institution_ids":["https://openalex.org/I4210151610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027892537","display_name":"Kanako Imataka","orcid":"https://orcid.org/0000-0002-4005-1166","observed_orcids":["https://orcid.org/0000-0002-4005-1166"]},"institutions":[{"id":"https://openalex.org/I4210151610","display_name":"Ise Red Cross Hospital","ror":"https://ror.org/047s1ww61","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210151610"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kanako Imataka","raw_affiliation_strings":["Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan","institution_ids":["https://openalex.org/I4210151610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083897559","display_name":"Kaoru \u00d4kubo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151610","display_name":"Ise Red Cross Hospital","ror":"https://ror.org/047s1ww61","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210151610"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kaoru Okubo","raw_affiliation_strings":["Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan","institution_ids":["https://openalex.org/I4210151610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080958017","display_name":"Yoshitaka Shirakura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151610","display_name":"Ise Red Cross Hospital","ror":"https://ror.org/047s1ww61","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210151610"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshitaka Shirakura","raw_affiliation_strings":["Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan","institution_ids":["https://openalex.org/I4210151610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113004913","display_name":"Kentaro Azuma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151610","display_name":"Ise Red Cross Hospital","ror":"https://ror.org/047s1ww61","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210151610"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kentaro Azuma","raw_affiliation_strings":["Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan","institution_ids":["https://openalex.org/I4210151610"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065188409","display_name":"Ryoko Fujiwara","orcid":"https://orcid.org/0000-0001-9619-4783","observed_orcids":["https://orcid.org/0000-0001-9619-4783"]},"institutions":[{"id":"https://openalex.org/I4210151610","display_name":"Ise Red Cross Hospital","ror":"https://ror.org/047s1ww61","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210151610"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ryoko Fujiwara","raw_affiliation_strings":["Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan","institution_ids":["https://openalex.org/I4210151610"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006072526","display_name":"Kazuya Murata","orcid":"https://orcid.org/0000-0003-2315-2923","observed_orcids":["https://orcid.org/0000-0003-2315-2923"]},"institutions":[{"id":"https://openalex.org/I4210151610","display_name":"Ise Red Cross Hospital","ror":"https://ror.org/047s1ww61","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I2799517759","https://openalex.org/I4210151610"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kazuya Murata","raw_affiliation_strings":["Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and Metabolism, Ise Red Cross Hospital, Mie,Japan","institution_ids":["https://openalex.org/I4210151610"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5001035577","https://openalex.org/A5006072526"],"corresponding_institution_ids":["https://openalex.org/I4210151610"],"apc_list":null,"apc_paid":null,"fwci":2.5585,"has_fulltext":false,"cited_by_count":96,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90213906,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"17","issue":"3","first_page":"293","last_page":"303"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9800000190734863},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8600000143051147},{"id":"https://openalex.org/keywords/muscle-mass","display_name":"muscle mass","score":0.9610000252723694},{"id":"https://openalex.org/keywords/fat-free-mass","display_name":"fat-free mass","score":0.9430000185966492},{"id":"https://openalex.org/keywords/muscle-loss","display_name":"muscle mass loss","score":0.8190000057220459},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6790000200271606},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9049999713897705},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.996999979019165},{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.996999979019165},{"id":"https://openalex.org/keywords/ipragliflozin","display_name":"ipragliflozin","score":0.9990000128746033}],"concepts":[{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.9337396025657654},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.890860915184021},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.8717397451400757},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8134685754776001},{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.7855914235115051},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6301863193511963},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.582677960395813},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5457725524902344},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5280210375785828},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5107519626617432},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4411023259162903},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4105771780014038},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3857802152633667},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3547176718711853},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.24513670802116394},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.14707490801811218},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009132","descriptor_name":"Muscles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1573399816666200705210006","doi":"https://doi.org/10.2174/1573399816666200705210006","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1573399816666200705210006","pdf_url":null,"source":{"id":"https://openalex.org/S204739293","display_name":"Current Diabetes Reviews","issn_l":"1573-3998","issn":["1573-3998","1875-6417"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Diabetes Reviews","raw_type":"journal-article"},{"id":"pmid:32628589","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32628589","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current diabetes reviews","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1556459089","https://openalex.org/W1591259115","https://openalex.org/W1910867164","https://openalex.org/W1965658712","https://openalex.org/W1967385770","https://openalex.org/W1975801154","https://openalex.org/W1998867833","https://openalex.org/W1999169081","https://openalex.org/W2003323316","https://openalex.org/W2009253656","https://openalex.org/W2031434074","https://openalex.org/W2038122313","https://openalex.org/W2046218459","https://openalex.org/W2091808438","https://openalex.org/W2098923148","https://openalex.org/W2100412101","https://openalex.org/W2102902846","https://openalex.org/W2115150337","https://openalex.org/W2126520659","https://openalex.org/W2130256776","https://openalex.org/W2130570549","https://openalex.org/W2135654340","https://openalex.org/W2136324712","https://openalex.org/W2138781309","https://openalex.org/W2151504182","https://openalex.org/W2167245776","https://openalex.org/W2176264944","https://openalex.org/W2262352538","https://openalex.org/W2283809486","https://openalex.org/W2311822206","https://openalex.org/W2519510391","https://openalex.org/W2604205657","https://openalex.org/W2615166425","https://openalex.org/W2773791657","https://openalex.org/W2788777662","https://openalex.org/W2808416526","https://openalex.org/W2810643620","https://openalex.org/W2889369238","https://openalex.org/W2890673765","https://openalex.org/W2896687076","https://openalex.org/W2903308693","https://openalex.org/W2904323762","https://openalex.org/W2921752535","https://openalex.org/W2954950466","https://openalex.org/W2974008202","https://openalex.org/W2977119607","https://openalex.org/W2989163806","https://openalex.org/W2997634477","https://openalex.org/W6604107555"],"related_works":["https://openalex.org/W4409180155","https://openalex.org/W7164887119","https://openalex.org/W4385472415","https://openalex.org/W4402992155","https://openalex.org/W2977119607","https://openalex.org/W7153163453","https://openalex.org/W7169638809","https://openalex.org/W7165385760","https://openalex.org/W3166174530","https://openalex.org/W7125017841"],"abstract_inverted_index":{"BACKGROUND:":[0],"When":[1,200],"considering":[2],"the":[3,29,45,85,113,124,130,156,185,198,203],"administration":[4],"of":[5,31,47,74,87,132,150],"glucagon-like":[6],"peptide-1":[7],"receptor":[8],"agonists":[9],"(GLP-1RAs),":[10],"sodium-glucose":[11],"cotransporter-2":[12],"(SGLT2)":[13],"inhibitors,":[14],"or":[15],"metformin,":[16,57],"it":[17,227],"is":[18,144,228],"important":[19,229],"to":[20,164,169,175,230,233],"understand":[21],"their":[22],"weight":[23,63,213,224],"loss":[24,33,225,235],"effect":[25],"as":[26,28,146],"well":[27],"degree":[30],"muscle":[32,59,91,151,234],"caused":[34],"by":[35],"each":[36],"drug":[37],"in":[38,64,155,181,194,239],"clinical":[39],"practice.":[40],"OBJECTIVE:":[41],"To":[42],"comparatively":[43],"examine":[44],"effects":[46,86,131],"GLP-1RAs":[48],"and":[49,56,61,93,99,171,208,219],"oral":[50],"antidiabetic":[51,88],"drugs,":[52],"including":[53],"SGLT2":[54],"inhibitors":[55],"on":[58,90,135],"mass":[60,92,137],"body":[62,94],"patients":[65],"with":[66,184,197,202],"type":[67],"2":[68],"diabetes":[69],"via":[70],"a":[71,107,178,191,211,222,237],"network":[72,109],"meta-analysis":[73],"randomized":[75,81,117],"controlled":[76,82,118],"trials.":[77],"METHODS:":[78],"We":[79],"included":[80,154],"trials":[83,119],"evaluating":[84],"drugs":[89,134],"weight.":[95],"Mean":[96],"difference":[97],"(MD)":[98],"95%":[100,161],"confidence":[101],"intervals":[102],"(CIs)":[103],"were":[104,139],"calculated":[105],"using":[106],"random-effects":[108],"meta-analysis.":[110],"RESULTS:":[111],"Of":[112],"studies":[114],"identified,":[115],"18":[116],"(1,":[120],"363":[121],"subjects)":[122],"satisfied":[123],"eligibility":[125],"criteria.":[126],"In":[127],"all":[128],"studies,":[129],"these":[133],"fat-free":[136],"(FFM)":[138],"evaluated.":[140],"Therefore,":[141],"FFM,":[142],"which":[143],"used":[145],"an":[147],"alternative":[148],"index":[149],"mass,":[152],"was":[153,241],"study.":[157],"Semaglutide":[158],"(MD:":[159],"-1.68,":[160],"CI:":[162],"-2.84":[163],"-0.52),":[165],"dapagliflozin":[166],"(-0.53,":[167],"-0.93":[168],"-0.13),":[170],"canagliflozin":[172,209,220],"(-0.90,":[173],"-1.73":[174],"-0.07)":[176],"showed":[177,210],"significant":[179,192,212],"decrease":[180,193,238],"FFM":[182,195,240],"compared":[183,196,201],"placebo.":[186,199],"Metformin":[187],"did":[188],"not":[189],"show":[190],"placebo,":[204],"semaglutide,":[205,217],"dapagliflozin,":[206],"ipragliflozin,":[207],"loss.":[214],"CONCLUSION:":[215],"Although":[216],"dapaglifrozin,":[218],"have":[221],"large":[223],"effect,":[226],"pay":[231],"attention":[232],"because":[236],"observed.":[242]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3040478654","counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":40},{"year":2024,"cited_by_count":21},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-07-10T00:00:00"}
